RBC Europe’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $41K | Hold |
500
| – | – | ﹤0.01% | 346 |
|
|
2022
Q1 | $39K | Hold |
500
| – | – | ﹤0.01% | 382 |
|
|
2021
Q4 | $44K | Hold |
500
| – | – | ﹤0.01% | 374 |
|
|
2021
Q3 | $38.6K | Hold |
500
| – | – | ﹤0.01% | 626 |
|
|
2021
Q2 | $41.7K | Hold |
500
| – | – | ﹤0.01% | 634 |
|
|
2021
Q1 | $37.8K | Hold |
500
| – | – | ﹤0.01% | 616 |
|
|
2020
Q4 | $43.8K | Hold |
500
| – | – | ﹤0.01% | 552 |
|
|
2020
Q3 | $38K | Hold |
500
| – | – | ﹤0.01% | 530 |
|
|
2020
Q2 | $61.7K | Sell |
500
-105
| -17% | -$13K | ﹤0.01% | 403 |
|
|
2020
Q1 | $51.1K | Sell |
605
-100
| -14% | -$8.45K | 0.01% | 383 |
|
|
2019
Q4 | $59.6K | Sell |
705
-525
| -43% | -$44.4K | 0.01% | 416 |
|
|
2019
Q3 | $82.9K | Sell |
1,230
-70
| -5% | -$4.72K | 0.01% | 364 |
|
|
2019
Q2 | $111K | Hold |
1,300
| – | – | 0.01% | 321 |
|
|
2019
Q1 | $115K | Hold |
1,300
| – | – | 0.01% | 307 |
|
|
2018
Q4 | $111K | Hold |
1,300
| – | – | 0.01% | 294 |
|
|
2018
Q3 | $126K | Hold |
1,300
| – | – | 0.01% | 317 |
|
|
2018
Q2 | $122K | Buy |
1,300
+800
| +160% | +$75.4K | 0.01% | 324 |
|
|
2018
Q1 | $40.5K | Hold |
500
| – | – | 0.01% | 502 |
|
|
2017
Q4 | $44.6K | Hold |
500
| – | – | 0.01% | 490 |
|
|
2017
Q3 | $46.5K | Buy |
+500
| New | +$46.5K | 0.01% | 485 |
|